Annual European Life Sciences CEO Forum

We are pleased to announce the 17th Annual European Life Sciences CEO Forum (#Sachs_ELSF), part of the Sachs Spring Life Sciences Week, which will also incorporate the 5th Annual European HealthTech CEO Forum.

The success and longevity of the forum is built on the goodwill and repeat attendance of major corporate and financial investors, and pharma licensing executives and advisors, who are seeking to network with biotechs. The programme and presentations allow all to keep up with the latest industry developments and strategize for 2024. The physical programme will consist of the usual panels and keynotes, which will be available on demand from the 6th of March. Additionally, there will be pre-arranged in-person meetings, live and on demand company showcases and a reception. During the online week, virtual meetings will be available through the audio/video online meeting system.

The main programme for the 17th Annual ELSF is spread throughout 2 days and will feature more than 12 hours of high-level keynotes and panel discussions. In addition, there will be a global company showcase of 50+ presentations by established public, private, emerging and seed companies, offering innovative solutions and seeking investment and partnering opportunities. This will include a limited number of live presentations taking place in dedicated presentation tracks, alongside virtual company showcases, which will be available on demand during the virtual week. We anticipate 400+ delegates will register for the forum from all Life Sciences sectors, with the target audience being corporate and financial investors/partners, banks and advisors with part of the audience participating virtually.

The In-Person meetings will be taking place on the 28th - 29th of February, while virtual meetings will take place on the 6th - 8th of March. For the virtual meetings, the system will allow you to have a secure audio/video call, as well as the option to present slides using a screen share function and we will have a dedicated room for in-person meetings. We expect 1800+ meetings completed during SSLSW. The conference will be held in the Central European Time Zone and the programme will consist of:

Day 1 (Wednesday, 28th of February)

• Industry Roundtable: Charting the Course for 2024
• Investment Outlook for VC & PE Panel: Focusing on Current Portfolio & Additions
• Cardiomet & Obesity Panel: Meeting the Huge Unmet Need
• Rare & Orphan Therapies Panel: Gene Therapy & Other Modalities
• Investing in NextGen ADC'S Panel
• Neuro Advances Panel: Highlighting the Main Opportunities

Day 2 (Thursday, 29th of February)

• Greater China Biopharma Panel: Potential Role in the European Life Science Industry
• Pharma Dealmakers Panel: Viewing the Challenges from Both Sides
• Oncology BD&L Panel: Keeping Pace with Market Needs
• Cancer Progress Panel: Advances in Therapeutics
• Early-Stage Investment Panel: Addressing the Funding Need
• Rising Stars: Global Biotech Seed Session

In-Person Meetings – 28th - 29th of February
Virtual Meetings via Online Meeting System – 6th - 8th of March
Networking Reception – 28th of February
On-Demand Content – from 6th of March

DISCOUNT FOR SWISS BIOTECH MEMBERS - 15%